Inhibition of IP3R3 expression leads to autophagic breast cancer cell death, and mitotic catastrophe in tumorigenic cells but not in normal cells (Bultynck, 2016; Cardenas et al., 2016; Singh et al., 2017a). Here, ITPR3 is linked to breast carcinoma.